Eicosapentaenoic acid suppresses palmitate-induced cytokine production by modulating long-chain acyl-CoA synthetase 1 expression in human THP-1 macrophages

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 289-296

  Nakakuki, Masanori ^a   Kawano, Hiroyuki ^a   Notsu, Tatsuto ^a   Imada, Kazunori ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

EPA; Fatty acid; Inflammation; Palmitate

Indexed keywords

CYTOKINE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LONG CHAIN ACYL COA SYNTHETASE 1; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; PALMITIC ACID; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MACROPHAGE; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

CELL LINE; COENZYME A LIGASES; CYTOKINES; EICOSAPENTAENOIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; JAPAN; MACROPHAGES; PALMITIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TOLL-LIKE RECEPTOR 4;

EID: 84875055017     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.12.036     Document Type: Article

References (31)

1. Imrie H., Abbas A., Kearney M. Insulin resistance, lipotoxicity and endothelial dysfunction. Biochim Biophys Acta 2010, 1801:320-326.
2. Prieur X., Roszer T., Ricote M. Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. Biochim Biophys Acta 2010, 1801:327-337.
3. Chapman M.J., Sposito A.C. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Pharmacol Ther 2008, 117:354-373.
4. Suganami T., Nishida J., Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 2005, 25:2062-2068.
5. Itoh M., Suganami T., Satoh N., et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 2007, 27:1918-1925.
6. Chinen I., Shimabukuro M., Yamakawa K., et al. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology 2007, 148:160-165.
7. Allayee H., Roth N., Hodis H.N. Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics. J Nutrigenet Nutrigenomics 2009, 2:140-148.
8. Chapkin R.S., Kim W., Lupton J.R., McMurray D.N. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009, 81:187-191.
9. Ariel A., Serhan C.N. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007, 28:176-183.
10. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
11. Lee J.Y., Hwang D.H. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells 2006, 21:174-185.
12. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001, 276:16683-16689.
13. Weatherill A.R., Lee J.Y., Zhao L., et al. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 2005, 174:5390-5397.
14. Lee J.Y., Ye J., Gao Z., et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003, 278:37041-37051.
15. Håversen L., Danielsson K.N., Fogelstrand L., Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 2009, 202:382-393.
16. Li L.O., Klett E.L., Coleman R.A. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Biochim Biophys Acta 2010, 1801:246-251.
17. Ikemoto S., Takahashi M., Tsunoda N., et al. Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease. Am J Physiol 1997, 273:E37-E45.
18. Sekiya M., Yahagi N., Matsuzaka T., et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38:1529-1539.
19. Yoshikawa T., Shimano H., Yahagi N., et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 2002, 277:1705-1711.
20. Lee J.Y., Zhao L., Youn H.S., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004, 279:16971-16979.
21. Erridge C., Samani N.J. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 2009, 29:1944-1949.
22. Zhao Y., Joshi-Barve S., Barve S., Chen L.H. Eicosapentaenoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation. J Am Coll Nutr 2004, 23:71-78.
23. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
24. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
25. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009, 27:165-197.
26. Stienstra R., Tack C.J., Kanneganti T.D., et al. The inflammasome puts obesity in the danger zone. Cell Metab 2012, 15:10-18.
27. Ma W., Gee K., Lim W., et al. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-κB transcription factors. J Immunol 2004, 172:318-330.
28. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokines 2008, 42:145-151.
29. Ruddock M.W., Stein A., Landaker E., et al. Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling. J Biochem 2008, 144:599-607.
30. Soupene E., Kuypers F.A. Mammalian long-chain acyl-CoA synthetases. Exp Biol Med 2008, 233:507-521.
31. Matsuda D., Namatame I., Ohshiro T., et al. Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor. J Antibiot 2008, 61:318-321.